Why a 10 mg Peptide Vial Does Not Contain 10 mg of Peptide

A synthetic peptide is weighed out and sold by the milligram. But some of those milligrams are salt and water, not peptide. This is normal chemistry, not fraud — and it is one of the reasons a certificate of analysis can be entirely truthful and still not tell you how much peptide is in the vial.

The short answer#

Two different numbers describe a peptide batch, and people constantly mix them up.

Purity is a ratio. It answers: of the material the detector saw, what fraction was the target peptide? That is what "99% by HPLC" means.

Content is a mass. It answers: how many milligrams of peptide are actually here? Nothing about the purity number answers that.

The gap between them exists because a lyophilised (freeze-dried) peptide powder is not pure peptide by weight. It is peptide plus counterions, plus bound water, plus whatever residual solvent survived drying. Supplier technical documentation puts the net peptide at roughly 60–80% of the measured gross weight for a typical synthetic peptide^[8].

So a vial labelled 10 mg, from a batch that is genuinely 99% pure, may hold somewhere near 7–8 mg of actual peptide. Both statements are true at once.

Where the missing mass goes#

Three things ride along with the peptide.

Counterions. Peptides have charged groups. Basic side chains — lysine, arginine, histidine — and the free amine at the N-terminus all carry a positive charge at the pH used in purification. Each of those needs a negative ion to balance it. That ion is part of the powder you weigh.

Water. Freeze-drying removes most water, not all of it. Peptides rich in charged residues also pull moisture back out of the air once the vial is opened.

Residual solvent. Traces of the organic solvents used in synthesis and purification — acetonitrile, DMF and others — can remain at low levels.

Only the first of these is usually large enough to change the arithmetic much, and it is entirely predictable from the sequence.

Why trifluoroacetate is the usual counterion#

Trifluoroacetic acid (TFA) does two jobs in standard solid-phase peptide synthesis. First it cleaves the finished chain off the resin and removes the side-chain protecting groups. Then it is used again, as an additive in the mobile phase, during reverse-phase HPLC purification.

The result is that the peptide comes out of the process as a trifluoroacetate salt. The count is set by chemistry, not by choice: roughly one TFA per basic residue, plus one for the free N-terminus.

That makes the arithmetic straightforward. Trifluoroacetic acid has a molecular weight of about 114. A 1,000-dalton peptide carrying two TFA counterions is about 1,000 / (1,000 + 228) — near 81% peptide by weight before you account for any water at all.

The counterion can be exchanged for something else, usually acetate or hydrochloride. Published comparisons of the available exchange methods found that they differ considerably in how completely they strip the TFA^[3]. Exchange is an extra step with an extra cost, so it is done when an application demands it and skipped when it does not.

Why HPLC purity cannot measure content#

Reverse-phase HPLC with UV detection is the standard purity method. The detector usually watches around 210–220 nm, where the peptide bond itself absorbs.

Two limits follow directly from how that works.

First, the method only counts what elutes from the column and absorbs at that wavelength. A counterion, water and many salts do not produce a peak. They are invisible to the measurement, which is exactly why they do not reduce the purity number.

Second, the method treats absorbance as proportional to mass, which is only approximately true. Different peptides — and different impurities — absorb differently. That makes UV-based area percent a semi-quantitative comparison of peaks, not an absolute mass measurement.

None of this is a flaw in HPLC. It is a purity assay doing its job. The error is asking it a content question.

How content is actually measured#

Two methods are the standard answer.

Amino acid analysis (AAA). The peptide is hydrolysed back into its individual amino acids, and those are separated and quantified against known standards. Because the sequence tells you how many of each amino acid a single molecule should contain, the amounts recovered give an absolute measure of how much peptide was in the sample. It has been evaluated as a reference method for quantifying highly purified proteins since the 1980s^[4].

Elemental analysis. Measuring the elemental composition — carbon, hydrogen, nitrogen — also yields an absolute content figure, and the fluorine signal can be used to quantify the TFA that is present.

Manufacturer quality-control documentation treats these content assays as a separate line item from purity, alongside identity, water content and residual solvents^[7]. That separation is the point: they are answering different questions and neither substitutes for the other.

The counterion is not always chemically silent#

There is a second reason this matters in a laboratory, beyond the arithmetic.

Residual trifluoroacetate has interfered with cell-based experiments. In cultured fetal rat osteoblasts, chondrocytes and mouse calvariae, trifluoroacetate reduced cell number and thymidine incorporation. When the same peptides were tested as TFA salts and as hydrochloride salts side by side, the results differed — in some cases enough to turn a proliferative effect into an apparent antiproliferative one^[2].

A 2025 review of TFA analysis and exchange makes the general version of the point: residual TFA can affect the accuracy and reproducibility of a range of cellular assays, which is why the review argues for a consistent standard on reporting and exchanging it^[1].

Read that carefully for what it is. This is a reproducibility problem in laboratory experiments — a reason two labs testing "the same" peptide can get different numbers. It is not a claim about what happens in a person, and none of these studies were done in people.

What regulated manufacturing does about this#

Approved peptide drugs are made under a quality system where content, purity, identity, water and residual solvents are all specified and tested at batch release. Impurities are not merely counted; above a threshold they must be identified individually.

The FDA has applied notably tight thresholds to synthetic peptides. Its 2021 guidance on abbreviated applications for certain highly purified synthetic peptides set out expectations for identifying and characterising peptide-related impurities, with identification required at levels as low as 0.10% of the drug substance^[5].

That guidance is now in flux. As of 28 July 2026, the FDA withdrew the 2021 document, saying it no longer reflects the agency's current scientific thinking, and published revised draft product-specific guidances for a set of peptide products^[6]. Anyone relying on the specifics should check the current status directly — this is exactly the kind of regulatory fact that goes stale.

The relevant contrast is simple. A product sold "for research use only" sits outside all of that. No rule requires its labelled milligrams to be net peptide milligrams, and no one audits whether they are.

What this changes about reading a certificate#

It adds one question to the list, and it is a question most certificates do not answer.

• Is there a content assay at all? Look for amino acid analysis or elemental analysis. Purity and mass spec do not cover it.
• Is the salt form stated? "TFA salt" or "acetate salt" tells you which counterion is in the mass. Nothing stated means nothing measured.
• Is water content reported? Karl Fischer titration or loss on drying. Otherwise the water is unaccounted for.
• Does the purity figure come with a chromatogram? A single number with no trace behind it cannot be checked.

The honest summary is that "99% pure, 10 mg" is not a contradiction of "about 7.5 mg of peptide". They are two compatible facts, and only one of them is usually printed.

The honest conclusion#

None of this is exotic. Peptide chemists have accounted for counterion and water mass since solid-phase synthesis became routine, and the reference methods for measuring content are decades old.

What is new is a retail market that quotes purity like a grade and weight like a guarantee, while omitting the assay that connects them. Knowing the difference between a ratio and a mass will not tell you whether any peptide does anything. It will tell you what a certificate of analysis has and has not measured — which is the only thing a certificate was ever able to do.

Where to go next#

• Peptide purity, contamination, and the limits of a certificate of analysis — the five things a CoA cannot tell you.
• How to read peptide research without falling for marketing — study types, the animal-to-human gap, and the common tricks.
• FDA-approved, off-label, investigational, unapproved: what each label means — why regulatory status is a separate axis from evidence.

Advertising disclosure: ads on this page are for NuNu Research, a research-use-only chemical storefront that shares an owner with PeptidesInfo. Ads never influence the evidence grades, regulatory statuses, or conclusions above, which come solely from the cited primary sources.